Impact on the budget of ONLS program of vedolizumab introduction for the treatment of inflammatory bowel disease

Impact on the budget of ONLS program of vedolizumab introduction for the treatment of inflammatory bowel disease

Aim. Evaluation of the impact on the budget of the program for the provision of necessary medications (ONLS program) for the inclusion of a new drug vedolizumab for the treatment of adult patients with moderate or severe active ulcerative colitis (UC) and moderate or severe active Crohn’s disease (C...

Full description

Bibliographic Details
Main Authors: S. K. Zyryanov, I. N. Dyakov, A. V. Veselov, V. N. Kashnikov
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2018-05-01
Series:Качественная клиническая практика
Subjects:
фармакоэкономика
анализ «влияния на бюджет»
ведолизумаб
воспалительные заболевания кишечника
язвенный колит
болезнь крона
моноклональные антитела
программа онлп
pharmacoeconomics
impact analysis on the budget
vedolizumab
inflammatory bowel disease
ulcerative colitis
crohn’s disease
monoclonal antibodies
onls program
Online Access:https://www.clinvest.ru/jour/article/view/104

Internet

https://www.clinvest.ru/jour/article/view/104

Similar Items